Softbank Just Backed This Silicon Valley Biotech Startup — Fortune

Japanese telecom conglomerate Softbank has led a massive, $130 million round in Zymergen, a three-year old Silicon Valley biotech startup. The company is trying to produce industrial chemicals from single-cell organisms, or microbes, to help make everything from surgical sutures to super fuel-efficient car parts. Zymergen is going after a massive opportunity–industrial chemicals that are…

via Softbank Just Backed This Silicon Valley Biotech Startup — Fortune

Advertisements